squibb
- Business
Karuna Therapeutics surges 47% after Bristol Myers Squibb declares $14 billion deal
Bristol Myers Squibb on Friday launched it agreed to aquire biopharmaceutical firm Karuna Therapeutics for $14 billion in money, or…
Read More »